Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases

Clinical Gastroenterology and Hepatology(2020)10.1016/j.cgh.2020.10.010Source: DataRank Database

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases is a research paper published in Clinical Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 48 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access48 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.92)OA: bronzeTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Bénédicte Pigneur ORCID,Gili Focht,Xian Zhang ORCID,Ryan C. Ungaro ORCID,Jean‐Frédéric Colombel ORCID

Live enrichment

PubMed:33059040 PMC:PMC7550063 OpenAlex:https://openalex.org/W3092364459

NCATS NIH HHS

Grant: UL1 TR002489

NIDDK NIH HHS

Grant: K23 DK111995

NIDDK NIH HHS

Grant: T32 DK007634

Leona M. and Harry B. Helmsley Charitable Trust

FWCI

0.92

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttp://www.cghjournal.org/article/S1542356520313999/pdf

publisherhttp://www.cghjournal.org/article/S1542356520313999/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1542356520313999?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356520313999?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cgh.2020.10.010

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchKawasaki Disease and Coronary ComplicationsAdolescentAmbulatory CareAnti-Inflammatory Agents, Non-SteroidalCOVID-19ChildColitis, UlcerativeComorbidityCrohn DiseaseFemaleHospitalizationHumansInflammatory Bowel DiseasesMaleMesalamineSARS-CoV-2SulfasalazineSystemic Inflammatory Response SyndromeTumor Necrosis Factor InhibitorsPediatric Crohn's diseasePediatric ulcerative colitispediatric multisystem inflammatory disease, COVID-19 related

MeSH Terms

Tumor Necrosis Factor InhibitorsCOVID-19SARS-CoV-2AdolescentAmbulatory CareAnti-Inflammatory Agents, Non-SteroidalChildColitis, UlcerativeCrohn DiseaseFemaleHospitalizationHumansMaleSulfasalazineInflammatory Bowel DiseasesComorbiditySystemic Inflammatory Response SyndromeMesalamine

Keywords

MedicineInflammatory bowel diseaseDiseaseCoronavirusEpidemiologyPandemicAngiotensin-converting enzyme 2Internal medicineImmunologyCrohn's diseaseGastroenterologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)